Active, not recruitingPhase 3NCT05464381
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)
Studying Inherited epidermolysis bullosa
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- RHEACELL GmbH & Co. KG
- Intervention
- allo-APZ2-OTS(drug)
- Enrollment
- 91 target
- Eligibility
- All sexes
- Timeline
- 2023 – 2027
Study locations (16)
- Sanatorio Mater Dei, Buenos Aires, Argentina
- EB-Haus Austria; Salzburger Landeskliniken (SALK), Salzburg, Austria
- Fundacion Debra Chile, Santiago, Chile
- Universitaetsklinik fuer Dermatologie und Allergologie, Nice, France
- Hospital Necker-Enfants Malades, Paris, France
- Service de Dermatologie Hospital Saint-Louis, Paris, France
- Andreas Syggros Hospital of Cutaneous Venereal Diseases, Athens, Greece
- Venereal & Skin Diseases Hospital of Thessaloniki, Thessaloniki, Greece
- Semmelweis Egyetem, Budapest, Hungary
- UOSD Pediatria-Alta Intensita di Curà, Ospedale Maggiore, Milan, Italy
- Ospedale Pediatrico Bambin Gesu, Roma, Italy
- Medical Concierge Centrum Medyczne, Warsaw, Poland
- Centro Hospitalar e Universitario de Comibra HUC, Coimbra, Portugal
- Hospital La Paz, Madrid, Spain
- Department of Dermatology, National Cheng Kung University, Tainan, Taiwan
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05464381 on ClinicalTrials.govOther trials for Inherited epidermolysis bullosa
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE3NCT05838092Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)RHEACELL GmbH & Co. KG
- ACTIVE NOT RECRUITINGNANCT05248503Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)Assistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT05954416FARD (RaDiCo Cohort) (RaDiCo-FARD)Institut National de la Santé Et de la Recherche Médicale, France